These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8999121)

  • 21. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
    Huang YC; Chiang CH; Yeh MK
    J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutaraldehyde cross-linked chitosan microspheres for controlled release of centchroman.
    Gupta KC; Jabrail FH
    Carbohydr Res; 2007 Nov; 342(15):2244-52. PubMed ID: 17610856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nifedipine loaded chitosan microspheres: characterization of internal structure.
    Singla AK; Sharma ML; Dhawan S
    Biotech Histochem; 2001 Jul; 76(4):165-71. PubMed ID: 11549129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours.
    Chandy T; Das GS; Rao GH
    J Microencapsul; 2000; 17(5):625-38. PubMed ID: 11038121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and characterization of cross-linked chitosan microspheres for drug delivery applications.
    Dini E; Alexandridou S; Kiparissides C
    J Microencapsul; 2003; 20(3):375-85. PubMed ID: 12881117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chitosan hydrochloride based microspheres of albendazole for colonic drug delivery.
    Rai G; Jain SK; Agrawal S; Bhadra S; Pancholi SS; Agrawal GP
    Pharmazie; 2005 Feb; 60(2):131-4. PubMed ID: 15739902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
    Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K
    Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterization of glutaraldehyde cross-linked O-carboxymethylchitosan microspheres for controlled delivery of pazufloxacin mesilate.
    Liu YF; Huang KL; Peng DM; Ding P; Li GY
    Int J Biol Macromol; 2007 Jun; 41(1):87-93. PubMed ID: 17292465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro--in vivo evaluation of tableted caseinchitosan microspheres containing diltiazem hydrochloride.
    al-Suwayeh SA; el-Helw AR; al-Mesned AF; Bayomi MA; el-Gorashi AS
    Boll Chim Farm; 2003; 142(1):14-20. PubMed ID: 12680034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface fabrication of hollow microspheres from N-methylated chitosan cross-linked with glutaraldehyde.
    Peng X; Zhang L
    Langmuir; 2005 Feb; 21(3):1091-5. PubMed ID: 15667195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lacidipine encapsulated gastroretentive microspheres prepared by chemical denaturation for pylorospasm.
    Sultana S; Bhavna ; Iqbal Z; Panda BP; Talegaonkar S; Bhatnagar A; Ahmad FJ
    J Microencapsul; 2009 Aug; 26(5):385-93. PubMed ID: 18720200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stomach-specific anti-H. pylori therapy; part III: effect of chitosan microspheres crosslinking on the gastric residence and local tetracycline concentrations in fasted gerbils.
    Hejazi R; Amiji M
    Int J Pharm; 2004 Mar; 272(1-2):99-108. PubMed ID: 15019073
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nifedipine loaded chitosan microspheres prepared by emulsification phase-separation.
    Dhawan S; Singla AK
    Biotech Histochem; 2003 Oct; 78(5):243-54. PubMed ID: 14989642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of chitosan and hydroxypropylchitosan in drug formulations to effect sustained release.
    Machida Y; Nagai T; Abe M; Sannan T
    Drug Des Deliv; 1986 Nov; 1(2):119-30. PubMed ID: 3509325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and improvement of release behavior of chitosan microspheres containing insulin.
    Wang LY; Gu YH; Su ZG; Ma GH
    Int J Pharm; 2006 Mar; 311(1-2):187-95. PubMed ID: 16436319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals.
    Thanoo BC; Sunny MC; Jayakrishnan A
    J Pharm Pharmacol; 1992 Apr; 44(4):283-6. PubMed ID: 1355537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Preparation and properties of 5-fluorouracil-loaded chitosan microspheres for the intranasal administration].
    Zheng AP; Yu SY; Zhao Y; Wu FL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 36(3):300-4. PubMed ID: 15205705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chitosan microspheres of diclofenac sodium: I. application of factorial design and evaluation of release kinetics.
    Açikgöz M; Kaş HS; Orman M; Hincal AA
    J Microencapsul; 1996; 13(2):141-59. PubMed ID: 8999120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Triamcinolone-loaded glutaraldehyde cross-linked chitosan microspheres: prolonged release approach for the treatment of rheumatoid arthritis.
    Dhanaraju MD; Elizabeth S; Gunasekaran T
    Drug Deliv; 2011 Apr; 18(3):198-207. PubMed ID: 21028952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.